Is yoghurt an acceptable alternative to raw milk for reducing eczema and allergy in infancy?

Abstract

We have recently completed a randomised controlled trial of maternal supplementation of the probiotic Lactobacillus rhamnosus HN001 (HN001), exploring effects on maternal and infant health. The methodology(1) and the maternal outcomes, gestational diabetes and symptoms of postnatal depression and anxiety have recently been published(2) (3). Briefly, mothers were randomised at 14-16 weeks gestation to receive HN001 (6x 10⁹ cfu) or placebo daily during pregnancy and for 6 months postpartum while breast feeding.

This article is protected by copyright. All rights reserved.

http://ift.tt/2GdlqU1